Part 864 Subpart H—Hematology Kits and Packages
FDA submissions for Part 864 Subpart H—Hematology Kits and Packages in the Hematology (HE) review panel, including product codes and regulations.
Section range: §§ 864.7010–864.7925
CFR Part: 864
Product Codes
| Product Code | Device Name | Regulation | Class | Devices |
|---|---|---|---|---|
| PWD | Flow Cytometric Test System For Hematopoietic Neoplasms | 864.7010 | 2 | 2 |
| JWR | Atp Release (Luminescence) | 864.7040 | 1 | 0 |
| KHF | Adenine Nucleotide Quantitation | 864.7040 | 1 | 0 |
| DDQ | Antigen, Antiserum, Control, Antithrombin Iii | 864.7060 | 2 | 4 |
| JBQ | Antithrombin Iii Quantitation | 864.7060 | 2 | 56 |
| JPE | Antithrombin Iii, Two Stage Clotting Time Assay | 864.7060 | 2 | 1 |
| JBE | Cell Enzymes (Erythrocytic And Leukocytic) | 864.7100 | 2 | 1 |
| LKZ | Red-Cell Count By Photometry | 864.7100 | 2 | 2 |
| JBP | Activated Whole Blood Clotting Time | 864.7140 | 2 | 24 |
| GGT | Assay, Erythropoietin | 864.7250 | 2 | 20 |
| JBO | Test, Euglobulin Lysis | 864.7275 | 2 | 1 |
| NPQ | Test, Factor V Leiden Mutations, Genomic Dna Pcr | 864.7280 | 2 | 6 |
| NPR | Test, Factor Ii G20210a Mutations, Genomic Dna Pcr | 864.7280 | 2 | 5 |
| OMM | Test 5, 10-Methylenetetrahydrofolate Reductase Mutations, Genomic Dna Pcr | 864.7280 | 2 | 2 |
| PHJ | System, Mass Spectrometry, Multiplex Genotyping, Hereditary Thrombophilia Related Mutations | 864.7280 | 2 | 1 |
| GGP | Test, Qualitative And Quantitative Factor Deficiency | 864.7290 | 2 | 190 |
| GJT | Plasma, Coagulation Factor Deficient | 864.7290 | 2 | 79 |
| QTY | Von Willebrand Factor Assay | 864.7293 | 2 | 1 |
| QLU | Anti-Factor Xa Activity Test System, Apixaban | 864.7295 | 2 | 3 |
| SAC | Adamts13 Activity Test System | 864.7297 | 2 | 1 |
| SES | Non-Factor Replacement Product Test System | 864.7298 | 2 | 1 |
| JBN | Fibrin Monomer Paracoagulation | 864.7300 | 2 | 2 |
| DAP | Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control | 864.7320 | 2 | 57 |
| GHH | Fibrin Split Products | 864.7320 | 2 | 28 |
| MIF | Prothrombin Fragment 1.2 | 864.7320 | 2 | 6 |
| DAR | Fibrinogen And Split Products, Rhodamine, Antigen, Antiserum, Control | 864.7340 | 2 | 0 |
| DAT | Fibrinogen And Split Products, Peroxidase, Antigen, Antiserum, Control | 864.7340 | 2 | 2 |
| DAX | Fibrinogen And Split Products, Fitc, Antigen, Antiserum, Control | 864.7340 | 2 | 0 |
| DAZ | Fibrinogen And Split Products, Antigen, Antiserum, Control | 864.7340 | 2 | 0 |
| GFK | Fibrinogen Determination Standards And Controls | 864.7340 | 2 | 1 |
| GFX | Fibrinogen Standard | 864.7340 | 2 | 3 |
| GIL | Plasma, Fibrinogen Control | 864.7340 | 2 | 8 |
| GIS | Test, Fibrinogen | 864.7340 | 2 | 13 |
| KQJ | System, Fibrinogen Determination | 864.7340 | 2 | 28 |
| JBF | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Screening | 864.7360 | 2 | 5 |
| JBG | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Spot | 864.7360 | 2 | 0 |
| JBH | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Micromethod | 864.7360 | 2 | 0 |
| JBI | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Catalase Inhibition | 864.7360 | 2 | 0 |
| JBJ | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Methemoglobin Reduction | 864.7360 | 2 | 0 |
| JBK | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), U.V. Kinetic | 864.7360 | 2 | 0 |
| JBL | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Quantitative | 864.7360 | 2 | 2 |
| JBM | Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Electrophoresis | 864.7360 | 2 | 0 |
| JLM | Isoenzymes, Electrophoretic, Glucose-6-Phosphate Dehydrogenase | 864.7360 | 2 | 1 |
| JMB | Visual, Semi-Quant. (Colorimetric), Glucose-6-Phosphate Dehydrogenase | 864.7360 | 2 | 1 |
| JMC | Nadp Reduction (U.V.), Glucose-6-Phosphate Dehydrogenase | 864.7360 | 2 | 0 |
| KQE | Assay, Erythrocytic Glucose-6-Phosphate Dehydrogenase | 864.7360 | 2 | 1 |
| GII | Glutathione, Red-Cell | 864.7375 | 2 | 0 |
| JMH | Fluorescence, Visual Observation (Qual., U.V.), Glutathione Reductase | 864.7375 | 2 | 0 |
| KQF | Assay, Glutathione Reductase | 864.7375 | 2 | 0 |
| JPD | Hemoglobin A2 Quantitation | 864.7400 | 2 | 13 |
| GIQ | Hemoglobin S | 864.7415 | 2 | 3 |
| GKA | Abnormal Hemoglobin Quantitation | 864.7415 | 2 | 23 |
| JCM | Control, Hemoglobin, Abnormal | 864.7415 | 2 | 12 |
| JPB | Hemoglobin M | 864.7415 | 2 | 0 |
| MLL | Hemoglobin C (Abnormal Hemoglobin Variant) | 864.7415 | 2 | 1 |
| GHS | Assay, Carboxyhemoglobin | 864.7425 | 2 | 5 |
| JBD | System, Analysis, Electrophoretic Hemoglobin | 864.7440 | 2 | 26 |
| GHA | Hemoglobin, Alkali Resistant | 864.7455 | 2 | 0 |
| GHQ | Stain, Fetal Hemoglobin | 864.7455 | 2 | 2 |
| JPC | Hemoglobin F Quantitation | 864.7455 | 2 | 1 |
| KQI | Assay, Fetal Hemoglobin | 864.7455 | 2 | 4 |
| LIM | Test, Screening, For D Positive Fetal Rbc'S | 864.7455 | 2 | 2 |
| LCP | Assay, Glycosylated Hemoglobin | 864.7470 | 2 | 249 |
| NGB | Test, Glycosylated Hemoglobin, Over The Counter | 864.7470 | 2 | 0 |
| NOZ | Assay, 1,5-Anhydroglucitol (15ag) | 864.7470 | 2 | 2 |
| GJC | Assay, Sulfhemoglobin | 864.7490 | 2 | 0 |
| GGF | Acid Hematin | 864.7500 | 2 | 0 |
| GGZ | Oxyhemoglobin | 864.7500 | 2 | 2 |
| GIG | Hemoglobinometer | 864.7500 | 2 | 3 |
| GJZ | Cyanomethemoglobin Reagent And Standard Solution | 864.7500 | 2 | 2 |
| GKK | Cyanomethemoglobin | 864.7500 | 2 | 7 |
| GLY | Oximeter To Measure Hemoglobin | 864.7500 | 2 | 5 |
| KHG | Whole Blood Hemoglobin Determination | 864.7500 | 2 | 39 |
| LGL | Assay, Bart'S, Hemoglobin | 864.7500 | 2 | 2 |
| QGU | Hemoglobin For Donor Testing | 864.7500 | 2 | 0 |
| GFT | Protamine Sulphate | 864.7525 | 2 | 2 |
| JBR | Test, Heparin Neutralization | 864.7525 | 2 | 3 |
| KFF | Assay, Heparin | 864.7525 | 2 | 46 |
| GHD | Test, Leukocyte Alkaline Phosphatase | 864.7660 | 1 | 4 |
| JCJ | Alkaline Phosphatase | 864.7660 | 1 | 0 |
| GIA | Test, Leukocyte Peroxidase | 864.7675 | 1 | 3 |
| LGO | Test, Leukocyte Typing | 864.7675 | 1 | 5 |
| LJX | Test, Urine Leukocyte | 864.7675 | 1 | 7 |
| LCO | Platelet Factor 4 Radioimmunoassay | 864.7695 | 2 | 13 |
| GGQ | Test, Prothrombin Consumption | 864.7720 | 2 | 2 |
| JPF | Prothrombin-Proconvertin And Thrombotest | 864.7735 | 2 | 0 |
| GJS | Test, Time, Prothrombin | 864.7750 | 2 | 127 |
| ODV | Vitamin K Epoxide Reductase Complex Subunit One (Vkorc1) Genotyping System | 864.7750 | 2 | 1 |
| GHM | Test, Sickle Cell | 864.7825 | 2 | 18 |
| JBB | Solubility, Hemoglobin, Abnormal | 864.7825 | 2 | 2 |
| GJA | Test, Thrombin Time | 864.7875 | 2 | 20 |
| GJB | Thrombin | 864.7875 | 2 | 1 |
| GKQ | Test, Thromboplastin Generation | 864.7900 | 1 | 1 |
| GFO | Activated Partial Thromboplastin | 864.7925 | 2 | 52 |
| GGO | Reagent, Thromboplastin And Control | 864.7925 | 2 | 1 |
| GGW | Test, Time, Partial Thromboplastin | 864.7925 | 2 | 32 |
| GIT | Reagent & Control, Partial Thromboplastin Time | 864.7925 | 2 | 4 |